Arzanova E, Mayrovitz HN (2022) The epidemiology of breast cancer. In: Mayrovitz HN (ed) Breast Cancer. Exon Publications, Brisbane. https://doi.org/10.36255/exon-publications-breast-cancer-epidemiology
Canadian Cancer Society / Société canadienne du cancer (2023) Canadian Cancer Statistics, Canadian Cancer Society. https://cancer.ca/en/research/cancer-statistics/canadian-cancer-statistics. Accessed 11 Jan 2024
Flemming JA, Djerboua M, Groome PA, Booth CM, Terrault NA (2021) NAFLD and alcohol-associated liver disease will be responsible for almost all new diagnoses of cirrhosis in Canada by 2040. Hepatology 74(6):3330–3344. https://doi.org/10.1002/hep.32032
Moo TA, Sanford R, Dang C, Morrow M (2018) Overview of breast cancer therapy. PET Clin 13(3):339–354. https://doi.org/10.1016/j.cpet.2018.02.006
Article PubMed PubMed Central Google Scholar
Shah R, Rosso K, Nathanson SD (2014) Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol 5(3):283–298. https://doi.org/10.5306/wjco.v5.i3.283
Article PubMed PubMed Central Google Scholar
Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W (2016) Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open 1(2):e000042. https://doi.org/10.1136/esmoopen-2016-000042
Article PubMed PubMed Central Google Scholar
Mahmud N, Fricker Z, Hubbard RA, Ioannou GN, Lewis JD, Taddei TH, Rothstein KD, Serper M, Goldberg DS, Kaplan DE (2021) Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology 73(1):204–218. https://doi.org/10.1002/hep.31558
Lichtman SM, Harvey RD, Damiette Smit MA, Rahman A, Thompson MA, Roach N, Schenkel C, Bruinooge SS, Cortazar P, Walker D, Fehrenbacher L (2017) Modernizing clinical trial eligibility criteria: recommendations of the american society of clinical oncology-friends of cancer research organ dysfunction, prior or concurrent malignancy, and comorbidities working group. J Clin Oncol 35(33):3753–3759. https://doi.org/10.1200/JCO.2017.74.4102
Article CAS PubMed Google Scholar
Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, Langenberg C, Golub RM, Loder EW, Gallo V, Tybjaerg-Hansen A, Davey Smith G, Egger M, Richards JB (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA 326(16):1614–1621. https://doi.org/10.1001/jama.2021.18236
Lapointe-Shaw L, Georgie F, Carlone D, Cerocchi O, Chung H, Dewit Y, Feld JJ, Holder L, Kwong JC, Sander B, Flemming JA (2018) Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study. PLoS One 13(8):e0201120. https://doi.org/10.1371/journal.pone.0201120
Article CAS PubMed PubMed Central Google Scholar
Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T (2009) Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J 16(6):183–188. https://doi.org/10.1155/2009/963098
Article PubMed PubMed Central Google Scholar
Lipscombe LL, Hwee J, Webster L, Shah BR, Booth GL, Tu K (2018) Identifying diabetes cases from administrative data: a population-based validation study. BMC Health Serv Res 18(1):316. https://doi.org/10.1186/s12913-018-3148-0
Article PubMed PubMed Central Google Scholar
Schultz SE, Rothwell DM, Chen Z, Tu K (2013) Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can 33(3):160–166
Article CAS PubMed Google Scholar
Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA (2007) Accuracy of administrative databases in identifying patients with hypertension. Open Med 1(1):e18–e26
PubMed PubMed Central Google Scholar
Jogendran M, Flemming JA (2024) Outcomes of gynecological and breast cancer among female patients with cirrhosis: scoping review of the literature. Canadian Liver Journal. https://doi.org/10.3138/canlivj-2023-0031
Olimpiadi YB, Brownson KE, Kahn JA, Kim B, Han H, Khemichian S, Fong TL, Kang I, Terando A, Lang JE (2020) Treatment and outcomes of early stage breast cancer in patients with hepatic dysfunction. J Surg Res 256:212–219. https://doi.org/10.1016/j.jss.2020.06.022
Article PubMed PubMed Central Google Scholar
Han EC, Ryoo SB, Park JW et al (2017) Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: a propensity-matched study. PLoS One 12(6):e0178920. https://doi.org/10.1371/journal.pone.0178920
Article CAS PubMed PubMed Central Google Scholar
Patel S, Brennan K, Zhang L, Djerboua M, Nanji S, Merchant S, Flemming J (2023) Colorectal cancer in individuals with cirrhosis: a population-based study assessing practice patterns, outcomes, and predictors of survival. Curr Oncol 30(11):9530–9541. https://doi.org/10.3390/curroncol30110690
Article PubMed PubMed Central Google Scholar
Refky B, Kotb S, Fady T, Marwan A, Abd El-Khalek D, Elnahas W, Hafez MT, Malik E, Soliman AA (2015) Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: a prospective study. BMC Cancer 15:754. https://doi.org/10.1186/s12885-015-1805-9
Article PubMed PubMed Central Google Scholar
Cabibbo G, Palmeri L, Palmeri S, Craxì A (2012) Should cirrhosis change our attitude towards treating non-hepatic cancer? Liver Int 32(1):21–27. https://doi.org/10.1111/j.1478-3231.2011.02629.x
Article CAS PubMed Google Scholar
Field KM, Michael M (2008) Part II: liver function in oncology: towards safer chemotherapy use. Lancet Oncol 9(12):1181–1190. https://doi.org/10.1016/S1470-2045(08)70307-3
Article CAS PubMed Google Scholar
Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR, MacSween RN (1999) Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 353(9146):36–37. https://doi.org/10.1016/S0140-6736(05)74872-8
留言 (0)